期刊文献+
共找到39篇文章
< 1 2 >
每页显示 20 50 100
IMMUNOCHEMICAL IDENTIFICATION AND LOCALIZATION OF CYTOCHROME P-450HSjISOZYME, AN ENZYME RELATED TO NITROSAMINE METABOLISM, IN HUMAN GASTRIC MUCOSA AND GASTRIC CARCINOMA
1
作者 方策 沈云英 +1 位作者 吴德丰 潘秀森 《Chinese Journal of Cancer Research》 SCIE CAS CSCD 1989年第2期19-23,共5页
Monoclonal antibody (MAb) to rat liver cyto-chrome P-450j isozyme, an activating enzyme specific to nitrosamine metabolism, was used coupled with immunoblotting, densitometer scanning of SDS-PAGE gels and immunohistoc... Monoclonal antibody (MAb) to rat liver cyto-chrome P-450j isozyme, an activating enzyme specific to nitrosamine metabolism, was used coupled with immunoblotting, densitometer scanning of SDS-PAGE gels and immunohistochemical technique. The trace P-450HSj isozyme (Mr. 51.5 Kd) was found in human gastric mucosa. It was similar to P-450j in molecular weight, catalytic and immunochemical properties. The concentrations of P-450HSj in mucosa of lesser curvature were higher than those in greater curvature. This might be one of the important reasons that lesser curvature is the commonest area for gastric carcinoma. But there was possibly less P-450HSj in gastric mucosa with cancer. Im-munohistochemically, P-450HSj was discovered in the cytoplasm of some glandular epithelial cells, especially in the glands with hyperplastic and intestinal metaplastic changes adjacent to carcinoma. It was also found in some normal glands and in tumor cells of high-differentiated adenocarcinoma, but not in those of low-differentiated ones. Following subjects are discussed: (1) the method of detecting trace P-450HSj, (2) the rule of distribution of P-450HSj, and (3) the relationship between the isozyme and the occurrence of gastric cancer caused by nitrosa-mines. 展开更多
关键词 IN HUMAN GASTRIC MUCOSA AND GASTRIC CARCINOMA AN enzyme RELATED TO NITROSAMINE METABOLISM IMMUNOCHEMICAL IDENTIFICATION AND LOCALIZATION OF cytochrome p-450HSjISOZYME NDEA
下载PDF
Effects of Yanhusuo(Rhizoma Corydalis),Baizhi(Radix Angelicae Dahuricae)and Their Combination Extracts on Cytochrome P450 Activities in Rats 被引量:1
2
作者 WANG Ping LI Sen +2 位作者 WANG Xu-guang WANG Shuang XU Hai-yu 《World Journal of Integrated Traditional and Western Medicine》 2021年第3期20-30,共11页
Background:Yuanhu Zhitong Prescription(元胡止痛方,YZP),a well-known herbal prescription for an analgesic effect,is recorded in the China Pharmacopoeia,consisting of Yanhusuo(Rhizoma Corydalis)and Baizhi(Radix Angelica... Background:Yuanhu Zhitong Prescription(元胡止痛方,YZP),a well-known herbal prescription for an analgesic effect,is recorded in the China Pharmacopoeia,consisting of Yanhusuo(Rhizoma Corydalis)and Baizhi(Radix Angelicae Dahuricae).Objective:To explore the influence of 70%EtOH extracts from Yanhusuo(Rhizoma Corydalis),Baizhi(Radix Angelicae Dahuricae)and YZP on the CYP450s,especially the differences between the single drug and prescription.Materials and methods:Cocktail probe drugs method was used to evaluate Cytochrome P450 activities in rat liver microsomes,including CYP1A2,CYP2D1,CYP2C11,CYP2C6 and CYP3A1,after rats repeatedly administrated with the extracts of Yanhusuo(Rhizoma Corydalis),Baizhi(Radix Angelicae Dahuricae)and YZP for 7 days.Results:Yanhusuo(Rhizoma Corydalis)extracts significantly increased the activities of CYP1A2,2C6 and 3A1,and inhibited that of 2D1.Baizhi(Radix Angelicae Dahuricae)extracts significantly increased the activities of CYP1A2 and inhibited that of 2D1 and 2C11.YZP extracts exhibited the same effect with single drugs.Conclusion:These results might partly interpret the TCM compatibility.Moreover,co-administration of prescriptions containing Yanhusuo(Rhizoma Corydalis),Baizhi(Radix Angelicae Dahuricae)or YZP should consider a potential herb(drug)-drug interaction medicated by the induction of CYP1A2,2C6 and 3A1 and inhibition of CYP2D1 and 2C11 enzymes. 展开更多
关键词 Yuanhu Zhitong Prescription(元胡止痛方) cytochrome P450 enzyme inhibition induction Herb(drug)-drug interaction.
下载PDF
Tobacco smoking and its drug interactions with comedications involving CYP and UGT enzymes and nicotine
3
作者 Naina Mohamed Pakkir Maideen 《World Journal of Pharmacology》 2019年第2期14-25,共12页
Tobacco smoking is a global public health threat causing several illnesses including cardiovascular disease(Myocardial infarction), cerebrovascular disease(Stroke), peripheral vascular disease(Claudication), chronic o... Tobacco smoking is a global public health threat causing several illnesses including cardiovascular disease(Myocardial infarction), cerebrovascular disease(Stroke), peripheral vascular disease(Claudication), chronic obstructive pulmonary disease, asthma, reduced female infertility, sexual dysfunction in men, different types of cancer and many other diseases. It has been estimated in 2015 that approximately 1.3 billion people smoke, around the globe. Use of medications among smokers is more common, nowadays. This review is aimed to identify the medications affected by smoking, involving Cytochrome P450(CYP)and uridine diphosphate-glucuronosyltransferases(UGTs) enzymes and Nicotine. Polycyclic aromatic hydrocarbons(PAHs) of tobacco smoke have been associated with the induction of CYP enzymes such as CYP1A1, CYP1A2 and possibly CYP2E1 and UGT enzymes. The drugs metabolized by CYP1A1,CYP1A2, CYP2E1 and UGT enzymes might be affected by tobacco smoking and the smokers taking medications metabolized by those enzymes, may need higher doses due to decreased plasma concentrations through enhanced induction by PAHs of tobacco smoke. The prescribers and the pharmacists are required to be aware of medications affected by tobacco smoking to prevent the toxicityassociated complications during smoking cessation. 展开更多
关键词 drug Interactions Tobacco smoking cytochrome P450 enzymeS URIDINE diphosphate-glucuronosyltransferases enzymeS NICOTINE
下载PDF
Effects of Tianma(Rhizoma Gastrodiae)and Gouteng(Ramulus Uncariae Rhynchophyllae cum Uncis)on cytochrome P450 enzyme activities in rats 被引量:3
4
作者 LIU Xin WANG Xinyu +1 位作者 PENG Yinxuan WANG Xing 《Journal of Traditional Chinese Medicine》 SCIE CSCD 2021年第2期284-292,共9页
OBJECTIVE:To investigate the efficacy of Tianma(Rhizoma Gastrodiae)and Gouteng(Ramulus Uncariae Rhynchophyllae cum Uncis)on cytochrome P450(CYP450)enzyme activities in rats.METHODS:A cocktail strategy was followed to ... OBJECTIVE:To investigate the efficacy of Tianma(Rhizoma Gastrodiae)and Gouteng(Ramulus Uncariae Rhynchophyllae cum Uncis)on cytochrome P450(CYP450)enzyme activities in rats.METHODS:A cocktail strategy was followed to evaluate the influence of Tianma(Rhizoma Gastrodiae)and Gouteng(Ramulus Uncariae Rhynchophyllae cum Uncis)on the activities of CYP450 isoforms(CYP1A2,CYP3A4,CYP2E1,CYP2C19,CYP2C9,CYP2D6),which were determined by changes in the pharmacokinetic parameters of six probe drugs,theophylline,dapsone,chlorzoxazone,omeprazole,tolbutamide and dextromethorphan.Study groups included,Control group(CG),Tianma(Rhizoma Gastrodiae)group(TM),Gouteng(Ramulus Uncariae Rhynchophyllae cum Uncis)group(GT)and Tianma Gouteng(Gastrodia Uncaria)group(TMGT).RESULTS:No significant differences between Tianma(Rhizoma Gastrodiae)and control groups were found.Compared with the control group,in the Gouteng(Ramulus Uncariae Rhynchophyllae cum Uncis)group both the AUC and t1/2 of dapsone and tolbutamide were reduced,whereas the CL(clearance rate)of dapsone and tolbutamide were increased.Compared with the control group,in the Tianma Gouteng group,the AUC and t1/2 of dapsone and tolbutamide were reduced,the CL of dapsone and tolbutamide were increased,and the AUC and t1/2 of chlorzoxazone were increased and the CL of chlorzoxazone was reduced.CONCLUSION:Tianma(Rhizoma Gastrodiae)has no significant effect on the six CYP450 subtypes.The activities of CYP3A4 and CYP2C9 were increased by Gouteng(Ramulus Uncariae Rhynchophyllae cum Uncis).The activities of CYP3A4 and CYP2C9 were increased,whereas the activity of CYP32E1 was reduced by combined Tianma(Rhizoma Gastrodiae)and Gouteng(Ramulus Uncariae Rhynchophyllae cum Uncis). 展开更多
关键词 Gastrodiae Elata Ramulus Uncariae Cum Uncis cytochrome p-450 enzyme system cocktail probe drug
原文传递
氟喹诺酮类药物对大鼠肝微粒体细胞色素P450酶系的影响 被引量:10
5
作者 张沂 于春令 +2 位作者 邸秀珍 赵猛 米媛媛 《解放军医学杂志》 CAS CSCD 北大核心 2012年第11期1059-1063,共5页
目的比较4种氟喹诺酮类药物[左氧氟沙星(LVFX)、加替沙星(GTFX)、莫西沙星(MXFX)、帕珠沙星(PZFX)]对大鼠肝微粒体细胞色素P450(CYP450)酶系的影响。方法 30只雄性Wistar大鼠随机分为空白对照组、LVFX组(LV组)、GTFX组(GT组)、MXFX组(MX... 目的比较4种氟喹诺酮类药物[左氧氟沙星(LVFX)、加替沙星(GTFX)、莫西沙星(MXFX)、帕珠沙星(PZFX)]对大鼠肝微粒体细胞色素P450(CYP450)酶系的影响。方法 30只雄性Wistar大鼠随机分为空白对照组、LVFX组(LV组)、GTFX组(GT组)、MXFX组(MX组)、PZFX组(PZ组),每组6只,给药方案为120mg/(kg.d),尾静脉注射给药,连续7d。末次给药后24h处死动物,差速离心法制备肝微粒体混悬液,Lowry法测定肝微粒体蛋白浓度,分光光度法检测肝微粒体CYP450酶系的含量及活性,并采用单因素方差分析进行统计。结果与空白对照组比较,MX组和GT组大鼠肝重明显降低(P<0.01,P<0.05),LV组、GT组和MX组大鼠肝微粒体蛋白浓度明显增加(P<0.01),LV组和GT组CYP450含量增加(P<0.05,P<0.01),GT组细胞色素b5(Cytb5)含量增加(P<0.05)。肝微粒体NADPH-CytC还原酶活性测定结果显示,给药组与空白对照组差异无统计学意义(P>0.05)。氨基吡啉-N-脱甲基酶活性测定结果显示,LV组、GT组和MX组酶活性与空白对照组比较差异均有统计学意义(P<0.01)。红霉素-N-脱甲基酶活性测定结果显示,与空白对照组比较,GT组酶活性降低,MX组酶活性升高,差异有统计学意义(P<0.01)。大鼠肝微粒体CYP450酶系亚家族活性检测结果显示,与空白对照组比较,LV组、MX组和PZ组7-苄基香豆素脱烃酶(BROD)活性升高(P<0.01),GT组7-甲氧基香豆素脱烃酶(MROD)活性降低(P<0.05)、7-苯基香豆素脱烃酶(PROD)活性增加,PZ组PROD活性降低(P<0.01),4种药物均可使乙氧基香豆素脱烃酶(EROD)活性增加(P<0.01)。结论 4种氟喹诺酮类药物对CYP450酶系均有肯定作用,对不同的酶其作用效果不同,从影响范围来看,GTFX、MXFX、LVFX和PZFX的作用依次减小。 展开更多
关键词 氧氟沙星 细胞色素P450酶系统 微粒体 代谢解毒 药物
下载PDF
Immunohistochemical localization of cytochrome P450 enzymes 2C and 4A in the normal rat brain
6
作者 黄存斌 《Chinese Medical Journal》 SCIE CAS CSCD 1998年第11期48-53,共6页
Objective To localize cytochrome P450 enzymes 4A and 2C in central nervous cells of normal male rats.Methods Eight drug/alcohol untreated normal male rats (150-200 g of body weight) were treated by the optimized perfu... Objective To localize cytochrome P450 enzymes 4A and 2C in central nervous cells of normal male rats.Methods Eight drug/alcohol untreated normal male rats (150-200 g of body weight) were treated by the optimized perfusion technique, then brain tissues were postfixed, paraffin-embedded and cut into series sections, which were labeled by the improved strept-avidin-biotin complex DAB-nickel enhancer (SABC-DAB-Ni) immunohistochemistry and hematoxylin & eosin (H & E) stain techniques.Results The immunohistochemical results indicated that P450 2C-11 enzyme was localized in diverse numbers of neurons as well as some neuroglial cells, with focal or defuse distribution in many brain regions such as cerebrum, thalamus, olfactory bulb, hypothalamus, brain-stem, hippocampus, cerebellum, interpositus nucleus, caudate-putamen, and globus pallidus. In contrast, no positive findings of P450 4A-2, 3 and 8 enzymes were obtained in the same animals. With high magnification, 2C-11 protein was able to be roughly observed on the endoplasmic reticulum of the rat neurons.Conclusions P450 2C-11 protein, rather than P450 4A-2, 3 and 8, may be a candidate of brain P450 enzymes in the normal male rats. 展开更多
关键词 Aryl Hydrocarbon Hydroxylases Steroid 16-alpha-Hydroxylase Animals BRAIN cytochrome p-450 enzyme System Immunohistochemistry Male RATS Rats Sprague-Dawley Steroid Hydroxylases
原文传递
“cocktail”探针药物法及其在研究中药对细胞色素P450影响中的应用进展 被引量:20
7
作者 候丛颂 杨志宏 孙晓波 《中国药理学与毒理学杂志》 CAS CSCD 北大核心 2013年第3期445-450,共6页
"cocktail"(鸡尾酒)探针药物法作为一种快速、高通量的研究方法,目前已广泛应用于药物对细胞色素P450(CYP450)活性影响评估、药物代谢途径确认、药物-药物相互作用预测、药物代谢表型分析、临床用药方案优化等诸多研究方向。... "cocktail"(鸡尾酒)探针药物法作为一种快速、高通量的研究方法,目前已广泛应用于药物对细胞色素P450(CYP450)活性影响评估、药物代谢途径确认、药物-药物相互作用预测、药物代谢表型分析、临床用药方案优化等诸多研究方向。此方法具有独特的优势和广阔的应用前景。本文主要从CYP450同工酶的特性、"cocktail"探针药物法的特点、探针药物选择依据、"cocktail"探针药物法在中药对CYP450代谢酶影响中的应用进行综述。旨在较为系统地梳理相关研究进展,并为此方面的深入研究工作提供参考。 展开更多
关键词 “cocktail”混合探针药物法 中草药 细胞色素P450酶系统 代谢
下载PDF
细胞色素氧化酶P450家族在中药毒性研究中的应用进展 被引量:10
8
作者 廖乃顺 陈文列 《中国药理学与毒理学杂志》 CAS CSCD 北大核心 2012年第3期402-405,共4页
细胞色素氧化酶P450(CYP)是最重要的药物代谢酶,多种中药能抑制或诱导CYP3A,CYP2C等亚型活性,而影响中药代谢,其中抑制作用是药物不良反应的主要原因;CYP1A2和CYP2E1等参与了中药前毒物的活化引起毒性反应。CYP参与中药代谢性相互作用,... 细胞色素氧化酶P450(CYP)是最重要的药物代谢酶,多种中药能抑制或诱导CYP3A,CYP2C等亚型活性,而影响中药代谢,其中抑制作用是药物不良反应的主要原因;CYP1A2和CYP2E1等参与了中药前毒物的活化引起毒性反应。CYP参与中药代谢性相互作用,故可通过对CYP抑制或诱导作用的分析,研究中药配伍减毒作用或配伍禁忌的毒性(增毒)作用;应重视研究中西药合用引起不良反应的CYP作用。本文综述了CYP在中药毒性研究中的应用概况,进一步展望CYP的应用前景,以期对中药毒性研究提供新思路。 展开更多
关键词 细胞色素P450酶系统 中草药 毒性作用
下载PDF
皮肤细胞色素P450酶的研究进展 被引量:1
9
作者 李珍 胡晋红 《药学服务与研究》 CAS CSCD 2008年第1期5-8,共4页
皮肤是肝外药物代谢的主要器官之一,有多种代谢酶表达。细胞色素P450酶(CYP)是一组含亚铁血红素的超家族基因编码的同工酶,皮肤CYP参与了多种内源性物质和外源性物质的代谢,在维持皮肤的正常生理功能和保护内环境稳定方面发挥重要作用... 皮肤是肝外药物代谢的主要器官之一,有多种代谢酶表达。细胞色素P450酶(CYP)是一组含亚铁血红素的超家族基因编码的同工酶,皮肤CYP参与了多种内源性物质和外源性物质的代谢,在维持皮肤的正常生理功能和保护内环境稳定方面发挥重要作用。对皮肤CYP的研究有助于了解它在药物代谢和皮肤疾病中的作用,对提高药物疗效、开发经皮给药新制剂、防止药物和毒性物质对皮肤的侵害等,具有重要意义。 展开更多
关键词 皮肤 细胞色素P450酶系统 综述 药物代谢
下载PDF
细胞色素P4501B1在上皮性卵巢癌组织中的表达
10
作者 朱壮彦 张慧娟 糜若然 《天津医药》 CAS 北大核心 2006年第5期304-305,T0002,共3页
目的:检测卵巢癌组织、卵巢良性上皮性肿瘤及正常卵巢组织中细胞色素P4501B1(cytochromeP4501B1,CYP1B1)的表达,为以CYP1B1为靶点进行卵巢癌治疗提供理论基础。方法:采用免疫组化SP法检测53例上皮性卵巢癌、30例卵巢良性上皮性肿瘤及19... 目的:检测卵巢癌组织、卵巢良性上皮性肿瘤及正常卵巢组织中细胞色素P4501B1(cytochromeP4501B1,CYP1B1)的表达,为以CYP1B1为靶点进行卵巢癌治疗提供理论基础。方法:采用免疫组化SP法检测53例上皮性卵巢癌、30例卵巢良性上皮性肿瘤及19例正常卵巢组织中CYP1B1的表达。结果:53例卵巢癌中CYP1B1阳性率92.45%,明显高于卵巢良性肿瘤组织(13.33%),差异有统计学意义(P<0.01)。正常卵巢组织CYP1B1呈阴性表达。14例同时收集的卵巢癌转移灶组织有13例CYP1B1阳性表达,阳性率为92.86%。结论:CYP1B1可作为一个抗癌药开发及逆转化疗药耐药的新靶点。 展开更多
关键词 卵巢肿瘤 细胞色素P450酶系统 抗肿瘤药 抗药性 肿瘤
下载PDF
延胡索乙素对映体对小鼠CYP450酶诱导和抑制作用研究 被引量:7
11
作者 赵鸣 李丽萍 +1 位作者 沈剑 蒋惠娣 《浙江大学学报(医学版)》 CAS CSCD 北大核心 2011年第1期33-39,共7页
目的:考察延胡索乙素(tetrahydropalmatine,THP)对映体对小鼠肝脏主要CYP450酶的体外抑制及体内诱导作用,从而预测其在临床上可能发生的代谢性药物相互作用,为临床合理用药提供科学依据。方法:以探针底物法,考察左旋延胡索乙素[(-)-tetr... 目的:考察延胡索乙素(tetrahydropalmatine,THP)对映体对小鼠肝脏主要CYP450酶的体外抑制及体内诱导作用,从而预测其在临床上可能发生的代谢性药物相互作用,为临床合理用药提供科学依据。方法:以探针底物法,考察左旋延胡索乙素[(-)-tetrahydropalmatine,(-)-THP]和右旋延胡索乙素[(+)-tetrahydropalmatine,(+)-THP]体外对小鼠肝微粒体主要Ⅰ相代谢酶CYP1A2、CYP2C、CYP2D22、CYP2E1、CYP3A11活性的影响;采用微粒体体外孵育"鸡尾酒"法(cocktail法),考察小鼠经高、低剂量(-)-THP和(+)-THP(240 mg/kg和60 mg/kg)连续灌胃7 d后,其肝微粒体中主要I相代谢酶活性的变化,以评价(-)-THP和(+)-THP对小鼠肝微粒体主要CYP450酶是否具诱导作用。结果:(-)-THP和(+)-THP体外对小鼠肝微粒体主要的CYP 450 I相代谢酶的抑制作用均不强,(+)-THP对CYP2C抑制的IC50为43.89μmol/L,两者对本研究考察的其它CYP亚型的IC50均大于100μmol/L;与溶剂处理组比较,小鼠经60 mg/kg和240 mg/kg的(-)-THP处理后,CYP1A2活性分别增加了68.7%和73.0%(P<0.05、P<0.01),经240 mg/kg的(-)-THP处理后,小鼠CYP2C37活性增加了80.4%(P<0.05),(-)-THP对其余CYP亚型活性未显示明显影响;(+)-THP对本研究考察的所有CYP亚型均未显示明显影响。结论:(-)-THP和(+)-THP体外对小鼠肝微粒体CYP主要亚型的抑制作用较弱;(-)-THP对小鼠肝微粒体CYP1A2、CYP2C37仅显示微弱的诱导作用,(+)-THP对小鼠肝微粒体主要CYP450酶亚型无明显诱导作用。 展开更多
关键词 延胡索乙素/药理学 延胡索乙素/投药和剂量 微粒体 肝/酶学 细胞色素P450酶系统/代谢 细胞色素P450酶系统/药物作用 酶诱导 细胞 培养的
下载PDF
表没食子儿茶素-3-没食子酸酯对细胞色素P450酶活性的影响
12
作者 韩秀媛 郭锡春 +3 位作者 张海霞 郝慧慧 张栋 李汉高 《精准医学杂志》 2021年第1期24-28,共5页
目的研究表没食子儿茶素-3-没食子酸酯(EGCG)对人肝微粒体中细胞色素P450(CYP450)酶活性的影响。方法以未处理的肝微粒体作为阴性对照组,CYP450酶各亚型的特异性抑制剂作为阳性对照组,通过EGCG或特异性抑制剂与探针底物共同孵育,高效液... 目的研究表没食子儿茶素-3-没食子酸酯(EGCG)对人肝微粒体中细胞色素P450(CYP450)酶活性的影响。方法以未处理的肝微粒体作为阴性对照组,CYP450酶各亚型的特异性抑制剂作为阳性对照组,通过EGCG或特异性抑制剂与探针底物共同孵育,高效液相色谱法定量分析特异性底物的代谢产物,分析EGCG对CYP450酶各亚型活性的影响,并通过统计学分析拟合获得相应的动力学参数。结果与阴性对照组相比,EGCG显著抑制了CYP1A2酶和CYP3A4酶的活性,但抑制作用远小于阳性抑制剂的抑制作用。EGCG对CYP1A2酶和CYP3A4酶的抑制作用受EGCG浓度的影响,IC50值分别为8.69和14.07μmol/L。EGCG能够竞争性抑制CYP1A2酶的活性,而对CYP3A4酶为非竞争性抑制作用。此外,EGCG对CYP3A4酶的抑制作用具有时间依赖性,随着培养时间的延长,抑制作用逐渐增强。结论EGCG可显著抑制CYP1A2酶及CYP3A4酶的活性。因此,在EGCG的应用中应充分考虑可能出现的药物相互作用及潜在风险。 展开更多
关键词 表没食子儿茶素没食子酸酯 细胞色素P450酶系统 细胞色素p-450 CYP1A2 细胞色素p-450 CYP3A4 微粒体 药代动力学 药物相互作用 体外研究
下载PDF
体外研究人细胞色素P450 3A4等位基因多态性对药物代谢和药物相互作用的影响 被引量:7
13
作者 李拴美 刘端 +1 位作者 朱娟莉 陈超 《中国医药生物技术》 CSCD 2009年第3期177-183,共7页
目的体外研究药物对人细胞色素P4503A4(CYP3A4)(野生型,WT)及其4个突变等位基因重组酶CYP3A4*3(M445T)、CYP3A4*4(I118V)、CYP3A4*17(F189S)和CYP3A4*18(L293P)的抑制程度。方法采用荧光高通量法和HPLC法分别测定WT及其4个突变等位基因... 目的体外研究药物对人细胞色素P4503A4(CYP3A4)(野生型,WT)及其4个突变等位基因重组酶CYP3A4*3(M445T)、CYP3A4*4(I118V)、CYP3A4*17(F189S)和CYP3A4*18(L293P)的抑制程度。方法采用荧光高通量法和HPLC法分别测定WT及其4个突变等位基因重组酶催化荧光底物——二甲基荧光素(DBF)脱烷基化和探针底物——硝苯地平氧化反应时的酶动力学参数;且通过测定大扶康、万络、西乐葆、酮康唑、地尔硫卓和维拉帕米的半数抑制浓度(IC50)值,确定6种药物对酶的抑制程度。结果除F189S外,其余4种重组酶均能催化DBF和硝苯地平反应生成相应的产物。各突变等位基因重组酶催化DBF反应的Km值(亲和力)与WT相当,M445T和L293P的内在清除率分别是WT的3.1和3.8倍(P<0.05),I118V是WT的1.3倍(P=0.1010)。各重组酶催化硝苯地平氧化反应的Km值均比WT小,I118V和L293P的内在清除率分别是WT的0.7和2.6倍(P<0.05),M445T与WT相当(P=0.7676)。6种药物对各重组酶的抑制程度强弱均为:酮康唑>地尔硫卓>维拉帕米>大扶康>西乐葆>万络;药物对各重组酶的IC50值大小为:WT<L293P<M445T<I118V。结论等位基因突变导致了酶动力学特征的改变和药物对酶抑制程度的不同,为进一步研究临床联合用药安全性奠定基础。 展开更多
关键词 细胞色素P450酶系统 多态性 单核苷酸 半数抑制浓度 药物相互作用
下载PDF
体外重组人细胞色素P450 2C9酿酒酵母表达体系的构建及其基因多态性对药物相互作用影响的初探 被引量:3
14
作者 马平平 王会娟 +1 位作者 朱娟莉 陈超 《中国医药生物技术》 CSCD 2009年第3期194-199,共6页
目的体外构建重组人细胞色素P450 2C9(CYP2C9)酿酒酵母(Saccharomyces cerevisiae)表达体系,且利用该体系研究药物对CYP2C9基因多态性酶抑制程度的差异性。方法将CYP2C9*1(野生型)和通过定点突变PCR法获得的等位基因突变克隆CYP2C9*2(R1... 目的体外构建重组人细胞色素P450 2C9(CYP2C9)酿酒酵母(Saccharomyces cerevisiae)表达体系,且利用该体系研究药物对CYP2C9基因多态性酶抑制程度的差异性。方法将CYP2C9*1(野生型)和通过定点突变PCR法获得的等位基因突变克隆CYP2C9*2(R144C突变体)和CYP2C9*3(I359L突变体)电穿孔转化酿酒酵母后,差速离心法制备酿酒酵母微粒体,蛋白免疫印迹法检测3种CYP2C9微粒体蛋白的表达;HPLC法检测CYP2C9*1与特异性底物双氯芬酸的反应,记录产物峰面积值,利用Prism Demo软件计算米氏常数(Km)值;利用荧光底物BOMCC对3个等位基因进行酶活性分析,分别计算Km、最大酶促反应速度(Vmax)和内在清除率。采用荧光高通量方法测定5种药物(甲苯磺丁脲、磺胺苯比唑、酮康唑、氟西汀和泰洛平)对酶的抑制程度。结果蛋白免疫印迹结果表明,3个等位基因均表达目的蛋白。CYP2C9*1代谢双氯芬酸的Km值为5.34±0.96μmol/L;以BOMCC为底物时,CYP2C9*1和CYP2C9*2的Km值分别为16.94±4.78、34.73±5.51μmol/L,Vmax分别为0.21±0.10、0.12±0.01pmol/(min·pmolP450),内在清除率分别为0.012±0.003、0.003±0.0001μl/(min·pmolP450);CYP2C9*3无催化活性。5种药物对CYP2C9*1的抑制程度:磺胺苯比唑>酮康唑>氟西汀>甲苯磺丁脲>泰洛平;对CYP2C9*2的抑制程度:磺胺苯比唑>甲苯磺丁脲>酮康唑>氟西汀>泰洛平。结论成功构建了重组人细胞色素CYP2C9及其多态性等位基因(CYP2C9*2、CYP2C9*3)酿酒酵母表达系统;初步建立了药物对CYP2C9基因多态性酶的抑制作用体外检测体系,为指导临床联合用药奠定了基础。 展开更多
关键词 细胞色素P450酶系统 多态性 单核苷酸 半数抑制浓度 药物相互作用
下载PDF
细胞色素P450基因多态性与药物性肝损伤的关系 被引量:7
15
作者 王巧玲 邹正升 《临床肝胆病杂志》 CAS 北大核心 2020年第5期1150-1153,共4页
随着药物性肝损伤患病率的逐年上升,药物性肝损伤发病机制成为了关注的焦点。CYP450酶作为一个庞大的家族,参与了药物在人体肝脏内的几乎所有氧化代谢反应。近年来发现CYP450酶的基因多态性导致了药效动力学在不同个体中的代谢差异性,... 随着药物性肝损伤患病率的逐年上升,药物性肝损伤发病机制成为了关注的焦点。CYP450酶作为一个庞大的家族,参与了药物在人体肝脏内的几乎所有氧化代谢反应。近年来发现CYP450酶的基因多态性导致了药效动力学在不同个体中的代谢差异性,故探索CYP450酶基因多态性在药物性肝损伤中的作用,可促进对药物性肝损伤发病机制的了解。对已发现与药物性肝损伤相关的CYP450酶基因多态性进行综述。 展开更多
关键词 细胞色素P450酶系统 多态现象 遗传 化学性与药物性肝损伤
下载PDF
高强度阿托伐他汀致肝损伤小鼠肠道菌群的改变及其与肝脏CYP2E 1的关系
16
作者 宋冰雪 宋雨晴 +3 位作者 刘鑫 于海初 辛辉 梁惠 《精准医学杂志》 2023年第6期494-498,共5页
目的探讨高强度阿托伐他汀(ATO)导致肝损伤小鼠肠道菌群的改变及其与肝组织中CYP2E1的关系。方法C57BL/6小鼠40只,按照处理方式不同分为4组,每组10只,低强度ATO组(ATO-L组)、中强度ATO组(ATO-M组)、高强度ATO组(ATO-H组)小鼠每天分别灌... 目的探讨高强度阿托伐他汀(ATO)导致肝损伤小鼠肠道菌群的改变及其与肝组织中CYP2E1的关系。方法C57BL/6小鼠40只,按照处理方式不同分为4组,每组10只,低强度ATO组(ATO-L组)、中强度ATO组(ATO-M组)、高强度ATO组(ATO-H组)小鼠每天分别灌胃含有10、20、30 mg/kg ATO的生理盐水1 mL,对照组(CON组)小鼠每天灌胃等量生理盐水,持续4周。HE染色后透射电镜下观察各组小鼠肝脏病理状态,检测各组小鼠血清中ALT、AST、TNF-α、IL-6和IL-10水平以及肝脏组织中SOD活力、CYP2E 1的mRNA水平,采用16SrDNA测序法分析小鼠新鲜粪便中肠道菌群分布,将差异有显著意义的菌属的相对丰度与肝脏组织中CYP2E 1 mRNA水平及SOD活力进行相关性分析。结果经HE染色及透射电镜下观察显示,ATO-M组、ATO-H组小鼠肝脏均出现不同程度的损伤现象;各组小鼠血清中ALT、AST、IL-6、TNF-α和肝脏组织中SOD活力差异有显著性(F=4.57~7.74,P<0.05)。ATO-H组小鼠肠道菌群稳态失衡,ATO-H组拟杆菌门、厚壁菌门、变形菌门和脱铁杆菌门的相对丰度与CON组比较,差异有显著性(t=2.89~5.22,P<0.05);两组紫单孢菌科、普氏菌科、乳杆菌科、毛螺菌科、螺杆菌科的相对丰度差异有显著性(t=2.45~5.46,P<0.05);两组螺杆菌属、拟普雷沃菌属、普氏菌属和乳杆菌属的相对丰度差异具有显著性(t=2.46~7.41,P<0.05)。乳杆菌属的相对丰度与肝脏组织SOD活力呈正相关(r=0.48,P<0.05),与肝组织中CYP2E 1的mRNA水平呈负相关(r=-0.62,P<0.05)。结论高强度他汀类药物可导致小鼠肠道菌群稳态失衡,抗氧化应激能力下降,肠道菌群乳杆菌属的减少可能会促进肝脏的氧化应激反应。 展开更多
关键词 胃肠道微生物组 阿托伐他汀 化学性与药物性肝损伤 细胞色素P450酶系统 RNA 信使 超氧化物歧化酶 乳杆菌属
下载PDF
Herb-drug enzyme-mediated interactions and the associated experimental methods: a review
17
作者 Li Bo Zhao Baosheng +4 位作者 Liu Yang Tang Mingmin Lǚe Beiran Luo Zhiqiang Zhai Huaqiang 《Journal of Traditional Chinese Medicine》 SCIE CAS CSCD 2016年第3期392-408,共17页
OBJECTIVE: To review the interactions between herbs and widely used drugs and summarize the associated experimental methods.METHODS: Definite herb-drug interactions were obtained by searching Pub Med, other large over... OBJECTIVE: To review the interactions between herbs and widely used drugs and summarize the associated experimental methods.METHODS: Definite herb-drug interactions were obtained by searching Pub Med, other large overseas databases and summarizing new researches from China. We summarize some methods to assess the interaction between herbs and drugs involving microsomal, cell culture and animal experiments, and clinical trials, classifying this method as single ingredient herbs, crude herb extracts, andherbal formulae.RESULTS: Many herbs interact with drugs through a complex cytochrome P450 and/or P-glycoprotein mechanism. Herb-induced enzyme inhibition and/or induction may result in enhanced and / or decreased plasma, tissue, urine and bile drug concentrations, leading to a change in a drug's pharmacokinetic parameters and resulting in the improper treatment of patients and potentially severe side effects. Use of an appropriate method for comprehensively assessing herb-drug interactions can minimize clinical risks. Different methods were used by researchers to assess the pharmacological changes of drugs in vivo and in vitro and the mechanisms of the interactions from microsomal, cell culture and animal experiments, and clinical trials are discussed in this review.CONCLUSION: Co-medication with herbs can result in changes in pharmacological effects of many drugs. This review describes the assessment of single-ingredient herbs, crude herb extracts, and herbal formulae. When choosing a research method to investigate herb-drug interactions, the properties of the drugs and herbs should be considered. 展开更多
关键词 Herb-drug interaction METABOLISM cytochrome p-450 enzyme system p-GLYCOPROTEIN REVIEW
原文传递
Effects of Ayurvedic Rasayana botanicals on CYP3A4 isoenzyme system
18
作者 Swapnil P.Borse Bhagyashree B.Kamble 《Journal of Integrative Medicine》 SCIE CAS CSCD 2015年第3期165-172,共8页
OBJECTIVE: Consuming botanical dietary supplements or herbal drugs along with prescription drugs may lead to potential pharmacokinetic-pharmacodynamic(PK-PD) herb-drug interactions(HDI). The present study focuses... OBJECTIVE: Consuming botanical dietary supplements or herbal drugs along with prescription drugs may lead to potential pharmacokinetic-pharmacodynamic(PK-PD) herb-drug interactions(HDI). The present study focuses on the importance of and novel approach for assessing HDI in integrative medicine with case examples of two frequently-used Ayurvedic Rasayana botanicals.METHODS: The aqueous extracts of Asparagus racemosus(ARE) and Gymnema sylvester(GSE) were prepared as per Ayurvedic Pharmacopoeia of India. Chemoprofiling of these extracts was done using high-performance liquid chromatography(HPLC). Additionally, ARE was characterized for the presence of shatavarins IV and I using HPLC & mass spectroscopy respectively. Effects of ARE and GSE were investigated on rat liver microsome using testosterone probe drug assay. The changes in formation of metabolite(6-β hydroxy testosterone) were monitored on incubation of testosterone alone, testosterone with ketoconazole, ARE and GSE using HPLC. Half inhibitory concentration(IC50) was used to predict plausible HDI.RESULTS: ARE and GSE showed no inhibition with IC50 values 〉1 000 μg/m L while the standard inhibitor ketoconazole completely abolished CYP3A4-dependent activity at 0.531 μg/m L and IC50 was found to be 0.036 μg/m L.CONCLUSION: ARE and GSE prepared as per Ayurvedic Pharmacopoeia of India were found to be safe for CYP3A4-mediated inhibitory HDI in rats. Our in vitro study suggests the need of further in vivo investigation for HDI in order to provide clinical relevance. 展开更多
关键词 drugs Chinese herbal AYURVEDA Asparagus racemosus Gymnema sylvester plant extracts cytochrome p-450 CYP3A herb-drug interactions
原文传递
药物性肝损伤的免疫学研究进展 被引量:11
19
作者 周璐 王邦茂 《胃肠病学》 2014年第11期641-643,共3页
药物性肝损伤(DILI)的发病机制未明,近年来的研究发现,免疫因素在DILI的发病中起重要作用。本文阐述免疫因素参与DILI发病的最新研究成果,探讨免疫因素参与DILI发病的机制,并比较免疫介导的DILI与药物诱发的自身免疫性肝炎的异同。DILI... 药物性肝损伤(DILI)的发病机制未明,近年来的研究发现,免疫因素在DILI的发病中起重要作用。本文阐述免疫因素参与DILI发病的最新研究成果,探讨免疫因素参与DILI发病的机制,并比较免疫介导的DILI与药物诱发的自身免疫性肝炎的异同。DILI免疫学研究的开展对DILI和自身免疫性肝炎的防治均具有重要意义。 展开更多
关键词 药物性肝损伤 自身免疫 细胞色素P450酶系统 肝炎 自身免疫性
下载PDF
新型口服抗凝药与抗逆转录病毒药物的相互作用 被引量:4
20
作者 张卫芳 鲍慧慧 +3 位作者 熊爱珍 夏晶 谢珊珊 梁佳 《药品评价》 CAS 2018年第10期12-15,33,共5页
随着更有效安全的抗逆转录病毒(Antiretroviral,ARV)药物的开发和应用,人类免疫缺陷病毒(Human immunodeficiency virus,HIV),即艾滋病病毒,HIV感染患者预期寿命已超过60岁。与普通人群相比,HIV感染的人群患心血管疾病如高血脂、心肌梗... 随着更有效安全的抗逆转录病毒(Antiretroviral,ARV)药物的开发和应用,人类免疫缺陷病毒(Human immunodeficiency virus,HIV),即艾滋病病毒,HIV感染患者预期寿命已超过60岁。与普通人群相比,HIV感染的人群患心血管疾病如高血脂、心肌梗死和心房颤动(Atrial fibrillation,AF)风险更高。同时进行ARV和心血管药物治疗的人群将越来越普遍。新型口服抗凝药(New oral anticoagulants,NOACs)在心血管领域主要用于不适合华法林抗凝的非瓣膜性房颤患者的替代治疗。随着其剂量固定、无需常规监测、患者服用依从性高等相对华法林应用上的优越性,目前在临床得到广泛应用,与其他药物的相互作用也逐渐被发现。本文通过查阅文献,系统综述NOACs和ARV药物之间药物相互作用(Drug-drug interactions,DDIs),为临床使用NOACs及联用ARV药物提供参考。 展开更多
关键词 新型口服抗凝药 抗逆转录病毒药 药物相互作用 细胞色素P450 p-糖蛋白
下载PDF
上一页 1 2 下一页 到第
使用帮助 返回顶部